Beam stock forecast.

TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comThis morning Beam, an insurtech startup that provides dental coverage to corporate employees, announced that it has closed an $80 million Series E. Mercato-affiliated Traverse led the investment, with Nationwide insurance joining the deal. ...(See BEAM stock forecast) CareDx, Inc . The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition. CareDx is a commercial-stage ...One 10 foot long 3.00″ x 0.17″ x 2.33″ standard steel I-beam from MetalsDepot.com costs $76.90. They have larger sizes available, such as the 10 foot long 8.00″ x 0.27″ x 4.00″ standard steel I-beam, which costs $248.40. Depending on size, ...

The average Beam Therapeutics stock forecast 2024 represents a 80.7% increase from the last price of $28.5900001525879. For Beam Therapeutics stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Beam Therapeutics stock forecast of $75.12, a high forecast of $83.03, and a low forecast of $61.46. The Vanguard Group, Inc. is the second largest shareholder owning 8.3% of common stock, and Arch Venture Partners, L.P. holds about 7.1% of the company stock. Furthermore, CEO John Evans is the ...Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.

The Fly Beam Therapeutics price target lowered to $26 from $35 at Barclays. 21d ago. Press Releases Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results. 22d ago. Press Releases Beam Therapeutics to Participate in 2023 Jefferies London Healthcare Conference. 22d ago.Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.

BEAM stock, the ticker symbol for Beam Therapeutics Inc, experienced a significant increase in its price on October 19, 2023. According to data from CNN Money, 14 analysts have provided 12-month price forecasts for the stock. The median target price is $61.00, with a high estimate of $105.00 and a low estimate of $27.00.Scores. BEAM has an Altman Z-Score of 1.39 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy. Altman Z-Score. 1.39. Piotroski F-Score. 2. Detailed statistics for Beam Therapeutics Inc. (BEAM) stock, including valuation metrics, financial numbers, share information and more.Dec 1, 2023 · John Evans. Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 and BEAM-102 for the treatment of sickle cell disease beta thalassemia; BEAM-201, an allogeneic chimeric antigen receptor T cell for the ... Nov 23, 2023 · Future criteria checks 2/6. CRISPR Therapeutics is forecast to grow earnings and revenue by 46.4% and 48.2% per annum respectively. EPS is expected to grow by 45.6% per annum. Return on equity is forecast to be 2% in 3 years.

(NASDAQ: SGMO) Sangamo Therapeutics's forecast annual revenue growth rate of -28.5% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.06%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.51%.

Find the latest Verve Therapeutics, Inc. (VERV) stock quote, history, news and other vital information to help you with your stock trading and investing.

Nov 29, 2023 · According to 3 stock analysts, the average 12-month stock price forecast for Beam Global stock is $26.67, which predicts an increase of 343.02%. The lowest target is $25 and the highest is $30. On average, analysts rate Beam Global stock as a strong buy. Next reporting date. February 13, 2024. EPS forecast (this quarter) -$0.20. Annual revenue (last year) $185.3M. Annual profit (last year) -$200.2M. Net profit margin.Find real-time SMG - Scotts Miracle-Gro Co stock quotes, company profile, news and forecasts from CNN Business.The current average BEAM price target, as estimated by these analysts, is $63.00. The predictions for the future BEAM stock price range from a low of $62.00 to a high of $66.00, highlighting the variability of market expectations for BEAM. Vroom, Inc. (NASDAQ:VRM) posted its earnings results on Tuesday, November, 7th. The company reported ($0.59) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.41) by $0.18. The company earned $235.63 million during the quarter, compared to analyst estimates of $223.90 million.Dec 1, 2023 · According to the issued ratings of 11 analysts in the last year, the consensus rating for Beam Therapeutics stock is Hold based on the current 6 hold ratings and 5 buy ratings for BEAM. The average twelve-month price prediction for Beam Therapeutics is $48.80 with a high price target of $105.00 and a low price target of $20.00. Learn more on ... See the latest Beam Global stock price (BEEM:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Track Beam Therapeutics Inc (BEAM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors४ दिन पहिले ... What is Beam Global's stock price today? Beam Global is currently listed on NASDAQ under BEEM. One share of BEEM stock can currently be ...See Beam Therapeutics Inc. (BEAM) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.BEEM stock forecast for 2023 – 2027. Last updated: November 25, 2023. BEEM. Beam Global. 5.85 D 4.84% (0.27) Are you interested in Beam Global stocks prediction? If yes, then on this page you will find useful information about the dynamics of the BEEM stock price in 2022-2027. Is BEEM a good long term stock? When should I …Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -8.44M. -19.71%. Get the latest Beam Global (BEEM) real-time quote ...

3 Wall Street research analysts have issued 12-month price targets for Beam Global's shares. Their BEEM share price targets range from $25.00 to $25.00. On average, they anticipate the company's stock price to reach $25.00 in the next year. This suggests a possible upside of 315.3% from the stock's current price.

Aug 26, 2023 · Beam Therapeutics (BEAM-1.72%), COMPASS Pathways (CMPS-6.05%), and 908 Devices (MASS-2.56%) are three ARK Invest holdings with strong buy ratings and exceptionally high price targets from the ... Find real-time UBER - Uber Technologies Inc stock quotes, company profile, news and forecasts from CNN Business.According to 9 stock analysts, the average 12-month stock price forecast for BEAM stock stock is $55.22, which predicts an increase of 93.14%. The lowest …Nov 25, 2023 · BEEM stock forecast for 2023 – 2027. Last updated: November 25, 2023. BEEM. Beam Global. 5.85 D 4.84% (0.27) Are you interested in Beam Global stocks prediction? If yes, then on this page you will find useful information about the dynamics of the BEEM stock price in 2022-2027. Is BEEM a good long term stock? When should I take profit in Beam ... Beam Therapeutics Stock Chart and Share Price Forecast, Short-Term "BEAM" Stock Prediction for Next Days and Weeks Walletinvestor.com Beam Therapeutics Inc (BEAM) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024 Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Iridium Communications Inc have a median target of 65.00, with a high estimate of 75.00 and a low estimate of 53.00. The ...Tritium shares are priced at $6.34 and their average price target of $14.40 implies an upside potential of ~127%. ( See Tritium stock forecast on TipRanks) Beam Global ( BEEM) Beam Global, the ...Chronic organ damage is the leading cause of death in adults with SCD. Beam is advancing multiple base editing programs for sickle cell disease, led by Beam-101, an ex vivo cell therapy in which cells are collected from a patient, edited, and then infused back into the patient. To create space for the edited cells to take hold in the bone ...Beam Global Stock Price, News & Analysis (NASDAQ:BEEM) $6.02 -0.12 (-1.95%) (As of 11/29/2023 ET) Compare Today's Range $6.01 $6.57 50-Day Range $5.35 …Tangshan Factory Hot Rolled Steel Profile H Beam I Beam with Stock Price, Find Details about Steel H Beam, H Beam from Tangshan Factory Hot Rolled Steel ...

... price action for Beam Therapeutics (BEAM) ... In the historical earnings table above, you can find BEAM historical earnings dates and the historical stock price ...

The current average BEAM price target, as estimated by these analysts, is $63.00. The predictions for the future BEAM stock price range from a low of $62.00 to a high of …

View Beam Global BEEM investment & stock information. Get the latest Beam Global BEEM detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Tomorrow's movement Prediction of Infibeam Incorp. INFIBEAM appears to be in uptrend. And this trend seems to be continuing further. Price is above an important level of 20.84 on charts, and as long as price remains …Find the latest UiPath Inc. (PATH) stock quote, history, news and other vital information to help you with your stock trading and investing.Based on short-term price targets offered by 16 analysts, the average price target for Alibaba comes to $126.50. The forecasts range from a low of $100.00 to a high of $150.00. The average price ...Stock Price Forecast. The 9 analysts offering 12-month price forecasts for Schrodinger Inc have a median target of 47.00, with a high estimate of 80.00 and a low estimate of 29.00. The median ...Oct 15, 2020 · The Beam Therapeutics stock forecast is 57.069107374265 USD for 2024 November 25, Monday; and 177.367 USD for 2028 November 25, Saturday with technical analysis. Beam Therapeutics (BEAM) stock price prediction is 57.069107374265 USD. BEEM Stock 12 Months Forecast. $24.00. (228.09% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Beam Global in the last 3 months. The average price target is $24.00 with a high forecast of $40.00 and a low forecast of $12.00. The average price target represents a 228.09% change from the last price of $7.32.Next reporting date. February 13, 2024. EPS forecast (this quarter) -$0.20. Annual revenue (last year) $185.3M. Annual profit (last year) -$200.2M. Net profit margin.

Beam has raised a $9.5 million Series A round. The company is working on a new web browser that completely rethinks the way you start a web session and browse the web. The startup is founded by Dom Leca and Sébastien Métrot. Dom Leca previo...The Biden administration is pushing hard to promote electric vehicles (EVs). From a $7.5 billion provision in the ‘Build Back Better’ bill to political pressure on automakers to commit to increased production with the goal of converting 40% of car sales to EVs by the end of this decade, it’s clear that under Biden, the government has the will to enforce a …Fiscal Q3 2023 ended 9/30/23. Get the latest Beam Therapeutics Inc (BEAM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading...Instagram:https://instagram. qqqq quotevanguard balancedtlt stocday trading with charles schwab A high-level overview of Beam Therapeutics Inc. (BEAM) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. rarest quarter in the worldsanofi aventis stock (See BEAM stock forecast) CareDx, Inc . The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition. CareDx is a commercial-stage diagnostics company that provides care for transplant patients, from finding the right match to follow-on surveillance post-transplant. how much is penny from 1943 worth October 30, 2023 at 7:00 AM · 5 min read. Wall Street expects a year-over-year increase in earnings on lower revenues when Beam Therapeutics Inc. (BEAM) reports results for the quarter ended ...BEAM Stock 12 Months Forecast. $43.44. (58.25% Upside) Based on 11 Wall Street analysts offering 12 month price targets for Beam Therapeutics in the last 3 months. The average price target is $43.44 with a high forecast of $75.00 and a low forecast of $19.00. The average price target represents a 58.25% change from the last price of $27.45.